Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 2808.68 | 7191.00 | 7094.50 | 1.0136 | 1.0203 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 7349.00 | 7094.50 | 1.0359 | 1.0534 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 5000.00 | 2808.68 | 2807.00 | 7094.50 | 0.3957 | -0.0004 |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7072.00 | 7094.50 | 0.9968 | 0.9953 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 113.00 | 105.50 | 1.0711 | 1.2563 | |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 156.25 | 71.09 | 158.00 | 105.50 | 1.4976 | 3.0647 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 156.25 | 71.09 | 81.00 | 105.50 | 0.7678 | 0.2575 |
| BT-20 | Linsitinib | 10 | uM | 9 | 156.25 | 71.09 | 104.00 | 105.50 | 0.9858 | 0.9503 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 156.25 | 71.09 | 192.00 | 105.50 | 1.8199 | 4.7234 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 156.25 | 71.09 | 327.00 | 105.50 | 3.0995 | 13.5780 |
| BT-20 | Erlotinib | 1 | uM | 9 | 156.25 | 71.09 | 132.00 | 105.50 | 1.2512 | 1.9643 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 156.25 | 71.09 | 109.00 | 105.50 | 1.0332 | 1.1180 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 132.00 | 105.50 | 1.2512 | 1.9643 | |
| BT-20 | Linsitinib | 1 | uM | 9 | 156.25 | 71.09 | 130.00 | 105.50 | 1.2322 | 1.8859 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 71.09 | 134.00 | 105.50 | 1.2701 | 2.0436 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 156.25 | 71.09 | 148.00 | 105.50 | 1.4028 | 2.6238 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 71.09 | 147.00 | 105.50 | 1.3934 | 2.5809 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 131.00 | 105.50 | 1.2417 | 1.9249 | |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 71.09 | 130.00 | 105.50 | 1.2322 | 1.8859 |
| BT-20 | Erlotinib | 10 | uM | 9 | 156.25 | 71.09 | 69.00 | 105.50 | 0.6540 | -0.0511 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 156.25 | 71.09 | 140.00 | 105.50 | 1.3270 | 2.2869 |
| BT-20 | Lapatinib | 10 | uM | 9 | 156.25 | 71.09 | 43.00 | 105.50 | 0.4076 | -0.5864 |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 84.00 | 105.50 | 0.7962 | 0.3404 | |
| BT-20 | 0 | uM | 9 | 156.25 | 71.09 | 122.00 | 105.50 | 1.1564 | 1.5813 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 156.25 | 71.09 | 121.00 | 105.50 | 1.1469 | 1.5443 |